acetyl isothiocyanate has been researched along with oxazoles in 1 studies
| Studies (acetyl isothiocyanate) | Trials (acetyl isothiocyanate) | Recent Studies (post-2010) (acetyl isothiocyanate) | Studies (oxazoles) | Trials (oxazoles) | Recent Studies (post-2010) (oxazoles) |
|---|---|---|---|---|---|
| 7 | 0 | 5 | 9,281 | 366 | 2,561 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czompa, A; Deme, R; Helyes, Z; Ludmerczki, R; Mátyus, P; Payrits, M; Sághy, É; Sándor, Z; Szőke, É | 1 |
1 other study(ies) available for acetyl isothiocyanate and oxazoles
| Article | Year |
|---|---|
A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium; Capsaicin; Cations, Divalent; Cell Line; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Isothiocyanates; Molecular Structure; Neurons; Neurotransmitter Agents; Oxazoles; Oximes; Rats, Wistar; Sensory System Agents; Trachea; Transient Receptor Potential Channels; Trigeminal Ganglion | 2016 |